Skip to main content

Advertisement

SpringerLink
Log in

Clinical Presentation, Staging and Long-Term Evolution of Parathyroid Cancer

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Parathyroid cancer is rare and often fatal. This review provides an in-depth analysis of 330 clinical cases reported in detail. These data are used to inform a proposal for a hitherto lacking TNM staging system.

Materials and Methods

All case reports or series with sufficient case details of parathyroid cancer were identified from PubMed, and data were analyzed using SPSS.

Results

Of 330 patients, 117 (35%) died of disease and 207 (63%) experienced recurrence in a total of 2007 follow-up years and a mean length of follow-up of 6.1 years. Histopathology findings rather than biochemical or clinical features predict outcome. In univariate analysis, survival and recurrence rates are significantly influenced by gender (male relative risk [RR] 1.7, 95% confidence interval [95% CI] 1.0–2.7, P < .01), and presence of vascular invasion (RR 4.3, 95% CI 1.1–17.7, P < .01), or lymph node metastases (RR 6.2, 95 %CI 0.9–42.9, P < .001). Failure to perform oncological surgery carries a high risk for recurrence and death (local versus en bloc resection RR 2.0, CI 1.2–3.2, P < .01) as for redo surgery. Staging by a novel anatomy-based TNM system identifies significant outcome variation as to recurrence and death. Separation of patients into low and high risk identifies a 3.5–7.0 fold higher risk of recurrence and death (P < .01) for the high-risk group. Distant metastases predominantly target mediastinum and lung.

Conclusion

Understaging and undertreatment are shown to contribute to high recurrence rates and death toll. To improve outcome, en bloc resection including central lymph node dissection should be the minimal surgical approach in any patient with suspected parathyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol. 1999;8:155–65.

    Article  CAS  PubMed  Google Scholar 

  2. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15:738–44.

    Article  CAS  PubMed  Google Scholar 

  3. Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med. 2007;37:286–302.

    Article  PubMed  Google Scholar 

  4. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32:676–80.

    Article  CAS  PubMed  Google Scholar 

  5. Fakhran S, Branstetter BFt, Pryma DA. Parathyroid imaging. Neuroimaging Clin N Am. 2008;18:537–49, ix.

    Article  PubMed  Google Scholar 

  6. Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: a collective review. Ann Surg. 1969;169:631–40.

    Article  CAS  PubMed  Google Scholar 

  7. Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid Carcinoma: Etiology, Diagnosis, and Treatment. World J Surg. 2009;33:2343–54.

    Article  PubMed  Google Scholar 

  8. Mallette LE, Bilezikian JP, Heath DA, Aurbach GD. Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore) 1974;53:127–46.

    CAS  Google Scholar 

  9. Mittendorf EA, McHenry CR. Parathyroid carcinoma. J Surg Oncol. 2005;89:136–42.

    Article  CAS  PubMed  Google Scholar 

  10. Poissonnet G, Castillo L, Bozec A, Peyrottes I, Ettore F, Santini J, et al. Parathyroid carcinoma. Bull Cancer. 2006;93:283–7.

    PubMed  Google Scholar 

  11. Rodgers SE, Perrier ND. Parathyroid carcinoma. Curr Opin Oncol. 2006;18:16–22.

    Article  PubMed  Google Scholar 

  12. Rawat N, Khetan N, Williams DW, Baxter JN. Parathyroid carcinoma. Br J Surg. 2005;92:1345–53.

    Article  CAS  PubMed  Google Scholar 

  13. DeLellis RA. Parathyroid carcinoma—An overview. Adv Anat Pathol. 2005;12:53–61.

    Article  PubMed  Google Scholar 

  14. Rao SR, Shaha AR, Singh B, Rinaldo A, Ferlito A. Management of cancer of the parathyroid. Acta Otolaryngol. 2002;122:448–52.

    Article  PubMed  Google Scholar 

  15. Bossola M, Tazza L, Ferrante A, Giungi S, Carbone A, Gui D, et al. Parathyroid carcinoma in a chronic hemodialysis patient: case report and review of the literature. Tumori. 2005;91:558–62.

    PubMed  Google Scholar 

  16. Boyle NH, Ogg CS, Hartley RB, Owen WJ. Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure and in coeliac disease. Eur J Surg Oncol. 1999;25:100–3.

    CAS  PubMed  Google Scholar 

  17. Djema AI, Mahmoud MD, Collin P, Heymann MF. [Tertiary hyperparathyroidism: parathyroid cancer with liver metastases in a hemodialyzed patient]. Nephrologie. 1998;19:121–3.

    CAS  PubMed  Google Scholar 

  18. Jayawardene S, Owen WJ, Goldsmith DJ. Parathyroid carcinoma in a dialysis patient. Am J Kidney Dis. 2000;36:E26.

    Article  CAS  PubMed  Google Scholar 

  19. Jimenez-Garcia A, Milan JA, Garcia-Escudero A, Marín-Velarde C, Cantillana J, Echenique-Elizondo M. Parathyroid carcinoma on transplanted parathyroid tissue after total parathyroidectomy for renal hyperparathyroidism. Am J Clin Oncol. 2006;29:207–8.

    Article  PubMed  Google Scholar 

  20. Khan MW, Worcester EM, Straus FH, 2nd, Khan S, Staszak V, Kaplan EL. Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg. 2004;199:312–9.

    Article  PubMed  Google Scholar 

  21. Miki H, Sumitomo M, Inoue H, Kita S, Monden Y. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery. 1996;120:897–901.

    Article  CAS  PubMed  Google Scholar 

  22. Pineda E, Perez-Ordonez B, Dackiw A, Jassal SV. Parathyroid carcinoma should be suspected in dialysis patients with rapid changes in serum parathormone levels. Perit Dial Int. 2005;25:93–4.

    CAS  PubMed  Google Scholar 

  23. Rademaker P, Meijer S, Oosterhuis JW, Vermey A, Zwierstra R, vd Hem G, et al. Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant. 1990;5:545–8.

    CAS  PubMed  Google Scholar 

  24. Srouji IA, Resouly A, Cree IA. Case of thymic parathyroid carcinoma in a haemodialysis patient: application of tumour chemosensitivity testing. J Laryngol Otol. 2004;118:162–4.

    Article  CAS  PubMed  Google Scholar 

  25. Takami H, Kameyama K, Nagakubo I. Parathyroid carcinoma in a patient receiving long-term hemodialysis. Surgery. 1999;125:239–40.

    Article  CAS  PubMed  Google Scholar 

  26. Tkaczyk M, Czupryniak A, Nowicki M. Ectopic mediastinal parathyroid carcinoma as a cause of dialysis-dependent renal failure. Hemodial Int. 2007;11:398–402.

    Article  PubMed  Google Scholar 

  27. Tominaga Y, Numano M, Uchida K, Sato K, Asano H, Haba T, et al. Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case. Surg Today. 1995;25:984–6.

    Article  CAS  PubMed  Google Scholar 

  28. Tseng CC, Huang JJ, Wang MC, Lan RR, Sung JM, Chen FF. Parathyroid carcinoma with multiple lung metastases. Nephrol Dial Transplant. 1999;14:449–51.

    Article  CAS  PubMed  Google Scholar 

  29. Geier A, Furst H, Laubach E, Stabler A, Riling R, Muller-Hocker J, et al. [Somnolence and vomiting in a patient after parathyroid gland carcinoma surgery]. Internist (Berl). 1999;40:311–5.

    Article  CAS  Google Scholar 

  30. Gittler RD, Maier H. Carcinoma of the parathyroid. Arch Intern Med. 1972;130:413–7.

    Article  CAS  PubMed  Google Scholar 

  31. Gray JH, Castillo F, Vasinrapee P. Multifocal parathyroid carcinoma in subtotal thyroidectomy. Clin Nucl Med. 2000;25:917–8.

    Article  CAS  PubMed  Google Scholar 

  32. Haghighi P, Astarita RW, Wepsic HT, Wolf PL. Concurrent primary parathyroid hyperplasia and parathyroid carcinoma. Arch Pathol Lab Med. 1983;107:349–50.

    CAS  PubMed  Google Scholar 

  33. Hirschel-Scholz S, Jung A, Fischer JA, Trechsel U, Bonjour JP. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma. Clin Endocrinol (Oxf). 1985;23:313–8.

    Article  CAS  Google Scholar 

  34. Holch P, Forray M, Emmermann A, Schroder S, Zornig C. [Parathyroid gland carcinoma with postoperative encephalopathy]. Chirurg. 2000;71:1489–92.

    Article  CAS  PubMed  Google Scholar 

  35. Kelly TR. Parathyroid carcinoma: a case report and review of the literature. Am Surg. 1969;35:374–6.

    CAS  PubMed  Google Scholar 

  36. Kirstein LJ, Ghosh BC. Intrathyroid parathyroid carcinoma. J Surg Oncol. 2001;77:136–8.

    Article  CAS  PubMed  Google Scholar 

  37. Kitapci MT, Tastekin G, Turgut M, Caner B, Kars A, Barista I, et al. Preoperative localization of parathyroid carcinoma using Tc-99 m MIBI. Clin Nucl Med. 1993;18:217–9.

    Article  CAS  PubMed  Google Scholar 

  38. Mansour KA, Letton AH. Adenocarcinoma of the parathyroid gland: review of the literature and report of one case. Am Surg. 1967;33:378–81.

    CAS  PubMed  Google Scholar 

  39. Pai M, Park CH, Kim BS, Chung YS, Park HB. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med. 1997;22:691–4.

    Article  CAS  PubMed  Google Scholar 

  40. Rossi P, Carillo FJ, Johnston B. Angiography in the diagnosis of parathyroid carcinoma. N Engl J Med. 1971;284:198–201.

    CAS  PubMed  Google Scholar 

  41. Sherif M, el-Bolkainy N, Khattar N. Carcinoma of the parathyroid gland. A case report and review of literature. J Egypt Med Assoc. 1970;53:71–8.

    CAS  PubMed  Google Scholar 

  42. Singer FR, Neer RM, Murray TM, Keutmann HT, Deftos LJ, Potts JT Jr. Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. N Engl J Med. 1970;283:634–6.

    Article  CAS  PubMed  Google Scholar 

  43. Singhal T, Jacobs M, Mantil JC. Tc-99 m pertechnetate/sestamibi subtraction scan in a case of parathyroid carcinoma. Clin Nucl Med. 2008;33:196–7.

    Article  PubMed  Google Scholar 

  44. Ahmad F, Strickland AD, Wright GM, Elabassy M, Kiruparan P, Bell PR, et al. Laparoscopic microwave tissue ablation of hepatic metastasis from a parathyroid carcinoma. Eur J Surg Oncol. 2005;31:321–2.

    Article  CAS  PubMed  Google Scholar 

  45. Bukowski RM, Sheeler L, Cunningham J, Esselstyn C. Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med. 1984;144:399–400.

    Article  CAS  PubMed  Google Scholar 

  46. Guazzi A, Gabrielli M, Guadagni G. Cytologic features of a functioning parathyroid carcinoma: a case report. Acta Cytol. 1982;26:709–13.

    CAS  PubMed  Google Scholar 

  47. Lee YT, Hutcheson JK. Mediastinal parathyroid carcinoma detected on routine chest films. Chest. 1974;65:354–5.

    CAS  PubMed  Google Scholar 

  48. Love GL, Samuels M. Fatal acute hyperparathyroidism and parathyroid carcinoma. South Med J. 1983;76:407–8.

    CAS  PubMed  Google Scholar 

  49. Pak CY, Wills MR, Smith GW, 2nd, Bartter FC. Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab. 1968;28:1657–60.

    Article  CAS  PubMed  Google Scholar 

  50. Sato K, Toraya S, Shiratori K, Kasagi Y, Mandai Y, Miyamoto T, et al. Appropriate intravenous doses of L-thyroxine and magnesium in a thyroidectomized patient with thyroid and parathyroid carcinomas receiving total parenteral nutrition during acute necrotizing pancreatitis. Intern Med. 1995;34:176–82.

    Article  CAS  PubMed  Google Scholar 

  51. Smith JF, Coombs RR. Histological diagnosis of carcinoma of the parathyroid gland. J Clin Pathol. 1984;37:1370–8.

    Article  CAS  PubMed  Google Scholar 

  52. Szmuilowicz ED, Utiger RD. A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy. Nat Clin Pract Endocrinol Metab. 2006;2:291–6; quiz 297.

    Article  PubMed  Google Scholar 

  53. Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, et al. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol. 2005;36:908–14.

    Article  CAS  PubMed  Google Scholar 

  54. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet. 2003;40:657–63.

    Article  CAS  PubMed  Google Scholar 

  55. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722–9.

    Article  CAS  PubMed  Google Scholar 

  56. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab. 2004;89:5583–91.

    Article  CAS  PubMed  Google Scholar 

  57. Haven CJ, van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, van Wezel T, et al. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol (Oxf). 2007;67:370–6.

    Article  CAS  Google Scholar 

  58. Vega EM, Mautalen CA. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma. Medicina (B Aires). 1991;51:106–10.

    CAS  Google Scholar 

  59. Newrick PG, Braatvedt GD, Webb AJ, Sheffield E, Corrall RJ. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate. Postgrad Med J. 1994;70:231–2.

    Article  CAS  PubMed  Google Scholar 

  60. Warrell RP, Jr., Issacs M, Alcock NW, Bockman RS. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma. Ann Intern Med. 1987;107:683–6.

    PubMed  Google Scholar 

  61. Schott M, Feldkamp J, Schattenberg D, Krueger T, Dotzenrath C, Seissler J, et al. Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol. 2000;142:300–6.

    Article  CAS  PubMed  Google Scholar 

  62. Bradwell AR, Harvey TC. Control of hypercalcaemia of parathyroid carcinoma by immunisation. Lancet. 1999;353:370–3.

    Article  CAS  PubMed  Google Scholar 

  63. Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, et al. Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma. J Clin Endocrinol Metab. 2004;89:3413–20.

    Article  CAS  PubMed  Google Scholar 

  64. Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol. 1993;17:820–9.

    Article  CAS  PubMed  Google Scholar 

  65. Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol. 2006;30:1140–9.

    PubMed  Google Scholar 

  66. Gimm O, Lorenz K, Thanh PN, Schneyer U, Bloching M, Howell VM, et al. Prophylactic parathyroidectomy for familial parathyroid carcinoma. Chirurg. 2006;77:15–24.

    Article  CAS  PubMed  Google Scholar 

  67. Ikeda K, Tate G, Suzuki T, Mitsuya T. Cytologic comparison of a primary parathyroid cancer and its metastatic lesions: A case report. Diagn Cytopathol. 2006;34:50–5.

    Article  PubMed  Google Scholar 

  68. Ireland JP, Fleming SJ, Levison DA, Cattell WR, Baker LR. Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck. J Clin Pathol. 1985;38:1114–8.

    Article  CAS  PubMed  Google Scholar 

  69. Johnson SJ, Sheffield EA, McNicol AM. Examination of parathyroid gland specimens. J Clin Pathol. 2005;58:338–42.

    Article  CAS  PubMed  Google Scholar 

  70. Montenegro FLD, Chammas MC, Juliano AG, Cernea CR, Cordeiro AC. Ethanol injection under ultrasound guidance to palliate unresectable parathyroid carcinoma. Arq Bras Endocrinol Metab. 2008;52:707–11.

    Article  Google Scholar 

  71. Obara T, Fujimoto Y, Hirayama A, Kanaji Y, Ito Y, Kodama T, et al. Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma. Cancer. 1990;65:1789–93.

    Article  CAS  PubMed  Google Scholar 

  72. Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, et al. Parathyroid neoplasms: Clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003;34:54–64.

    Article  PubMed  Google Scholar 

  73. Szende B, Farid P, Vegso G, Perner F, Kopper L. Apoptosis and p53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Path Oncol Res. 2004;10:98–103.

    Article  CAS  Google Scholar 

  74. Valdivielso P, Lopez-Sanchez J, Garrido A, Sanchez-Carrillo JJ. Metastatic calcifications and severe hypercalcemia in a patient with parathyroid carcinoma. J Endocrinol Invest. 2006;29:641–4.

    CAS  PubMed  Google Scholar 

  75. Fuster D, Torregrosa JV, Esteve V, Ybarra J, Sabater L, Alós L, et al. [Parathyroid carcinoma associated to secondary hyperparathyroidism in hemodialyzed patients. Two cases reports]. Nefrologia. 2007;27:209–13.

    CAS  PubMed  Google Scholar 

  76. Collins FD, Warren MC, Palmer FJ, Rankin DR. Nonfunctioning parathyroid carcinoma: a case history. J Surg Oncol. 1986;31:60–1.

    Article  CAS  PubMed  Google Scholar 

  77. Mazeh H, Prus D, Freund HR. Incidental non-functional parathyroid carcinoma identified during thyroidectomy. Isr Med Assoc J. 2008;10:659.

    PubMed  Google Scholar 

  78. Favia G. [Up-date on parotid gland surgery]. Ann Ital Chir. 2003;74:379–80.

    CAS  PubMed  Google Scholar 

  79. Sandelin K, Tullgren O, Farnebo LO. Clinical course of metastatic parathyroid cancer. World J Surg. 1994;18:594–8; discussion 599.

    Article  CAS  PubMed  Google Scholar 

  80. van Heerden JA, Weiland LH, ReMine WH, Walls JT, Purnell DC. Cancer of the parathyroid glands. Arch Surg. 1979;114:475–80.

    PubMed  Google Scholar 

  81. Aldinger KA, Hickey RC, Ibanez ML, Samaan NA. Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer. Cancer. 1982;49:388–97.

    Article  CAS  PubMed  Google Scholar 

  82. Abrahams TG, Hanks P, Jones M. Hyperfunctioning parathyroid carcinoma. Skeletal Radiol. 2000;29:112–5.

    Article  CAS  PubMed  Google Scholar 

  83. Al-Sobhi S, Shira H, Al-Dayel F, Ahmed M, Ingemansson S. Parathyroid carcinoma: A report of two cases. Ann Saudi Med. 1999;19:431–3.

    CAS  PubMed  Google Scholar 

  84. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, Ordonez NG, Hickey RC.: Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery. 1983;94:906–15.

    CAS  PubMed  Google Scholar 

  85. Artinyan A, Guzman E, Maghami E, Al-Sayed M, D’Apuzzo M, Wagman L, et al. Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization. J Clin Oncol. 2008;26:4039–41.

    Article  PubMed  Google Scholar 

  86. Aso Y, Sato A, Tayama K, Takanashi K, Satoh H, Takemura Y. Parathyroid carcinoma with metastatic calcification identified by technetium-99 m methylene diphosphonate scintigraphy. Intern Med. 1996;35:392–5.

    Article  CAS  PubMed  Google Scholar 

  87. Au WY. Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on long-term treatment of hypercalcemia. Arch Intern Med. 1975;135:1594–7.

    Article  CAS  PubMed  Google Scholar 

  88. Bhansali A, Kataria RN, Dutta P, Saha MM, Singh P, Dash RJ. Parathyroid carcinoma: difficult management options. Indian J Cancer. 2002;39:119–22.

    CAS  PubMed  Google Scholar 

  89. Brown JJ, Mohamed H, Williams-Smith L, Osborne R, Coker J, Yee B. Primary hyperparathyroidism secondary to simultaneous bilateral parathyroid carcinoma. Ear Nose Throat J. 2002;81:395–8, 400–1.

    Google Scholar 

  90. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.

    Article  PubMed  Google Scholar 

  91. Calandra D, Shah K, Lawrence AM, Paloyan E. Parathyroid carcinoma. A report of five cases. Am Surg. 1985;51:372–4.

    CAS  PubMed  Google Scholar 

  92. Caley JP, Jones EE, Collins DH. Fatal recurrence of parathyroid carcinoma after seven years. J Clin Pathol. 1962;15:438–45.

    Article  CAS  PubMed  Google Scholar 

  93. Cheah WK, Rauff A, Lee KO, Tan W. Parathyroid carcinoma: a case series. Ann Acad Med Singapore. 2005;34:443–6.

    CAS  PubMed  Google Scholar 

  94. Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid carcinoma—the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1998;41:569–72.

    Article  CAS  PubMed  Google Scholar 

  95. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004;100:900–5.

    Article  PubMed  Google Scholar 

  96. Cohn K, Silverman M, Corrado J, Sedgewick C. Parathyroid carcinoma: the Lahey Clinic experience. Surgery. 1985;98:1095–100.

    CAS  PubMed  Google Scholar 

  97. Crescenzo DG, Shabahang M, Garvin D, Evans SR. Intrathyroidal parathyroid cancer presenting as a left neck mass. Thyroid. 1998;8:597–9.

    Article  CAS  PubMed  Google Scholar 

  98. de la Garza S, Flores de la Garza E, Hernandez Batres F. Functional parathyroid carcinoma. Cytology, histology, and ultrastructure of a case. Diagn Cytopathol. 1985;1:232–5.

    Article  PubMed  Google Scholar 

  99. de Papp AE, Kinder B, LiVolsi V, Gupta SM, Stewart AF. Parathyroid carcinoma arising from parathyroid hyperplasia: autoinfarction following intravenous treatment with pamidronate. Am J Med. 1994;97:399–400.

    Article  PubMed  Google Scholar 

  100. Demirjian AN, Grossman JM, Chan JL, Parangi S. Parathyroid carcinoma and neurofibromatosis. Surgery. 2008;144:827–9.

    Article  PubMed  Google Scholar 

  101. Desch CE, Arsensis G, Woolf PD, May AG, Amatruda JM. Parathyroid hyperplasia and carcinoma within one gland. Am J Med. 1984;77:131–4.

    Article  CAS  PubMed  Google Scholar 

  102. Dotzenrath C, Goretzki PE, Sarbia M, Cupisti K, Feldkamp J, Röher HD. Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease. Eur J Surg Oncol. 2001;27:383–9.

    Article  CAS  PubMed  Google Scholar 

  103. Dubost C, Jehanno C, Lavergne A, Le Charpentier Y. Successful resection of intrathoracic metastases from two patients with parathyroid carcinoma. World J Surg. 1984;8:547–51.

    Article  CAS  PubMed  Google Scholar 

  104. Ellis HA, Floyd M, Herbert FK. Recurrent hyperparathyroidism due to parathyroid carcinoma. J Clin Pathol. 1971;24:596–604.

    Article  CAS  PubMed  Google Scholar 

  105. Eurelings M, Frijns CJ, Jeurissen FJ. Painful ophthalmoplegia from metastatic nonproducing parathyroid carcinoma: case study and review of the literature. Neuro Oncol. 2002;4:44–8.

    Article  PubMed  Google Scholar 

  106. Flye MW, Brennan MF. Surgical resection of metastatic parathyroid carcinoma. Ann Surg. 1981;193:425–35.

    Article  CAS  PubMed  Google Scholar 

  107. Fujimoto Y, Obara T, Ito Y, Kanazawa K, Aiyoshi Y, Nobori M. Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection. World J Surg. 1984;8:392–400.

    Article  CAS  PubMed  Google Scholar 

  108. Fujimoto Y, Obara T, Ito Y, Kodama T, Nobori M, Ebihara S. Localization and surgical resection of metastatic parathyroid carcinoma. World J Surg. 1986;10:539–47.

    Article  CAS  PubMed  Google Scholar 

  109. Gale TC, Owens CW. Hyperfunctioning carcinoma of the parathyroid gland. Postgrad Med J. 1972;48:626–31.

    Article  CAS  PubMed  Google Scholar 

  110. Gogas J, Kalos A, Skalkeas G. Functioning metastatic parathyroid carcinoma. Am Surg. 1975;41:419–21.

    CAS  PubMed  Google Scholar 

  111. Gottswinter JM, Ziegler R, Weise HJ, Baczako K, Heymer B, Herfarth C. [Parathyroid carcinoma]. Klin Wochenschr. 1984;62:613–20.

    Article  CAS  PubMed  Google Scholar 

  112. Grodski S, Serpell J. Evidence for the role of perioperative PTH measurement after total thyroidectomy as a predictor of hypocalcemia. World J Surg. 2008;32:1367–73.

    Article  PubMed  Google Scholar 

  113. Hara H, Oyama T, Kimura M, Ishii E, Chiba S, Takasou K, et al. Cytologic characteristics of parathyroid carcinoma: a case report. Diagn Cytopathol. 1998;18:192–8.

    Article  CAS  PubMed  Google Scholar 

  114. Harris NL. Case records of the Massachusetts General Hospital—continuing to learn from the patient. N Engl J Med. 2003;348:2252–4.

    Article  PubMed  Google Scholar 

  115. Iacobone M, Lumachi F, Favia G. Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol. 2004;88:223–8.

    Article  PubMed  Google Scholar 

  116. Iihara M, Okamoto T, Suzuki R, Kawamata A, Nishikawa T, Kobayashi M, et al. Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis. Surgery. 2007;142:936–43; discussion 943.

    Article  PubMed  Google Scholar 

  117. Ito Y, Iwase H, Tanaka H, Yuasa H, Kureyama Y, Yamashita H, et al. Metachronous primary hyperparathyroidism due to a parathyroid adenoma and a subsequent carcinoma: report of a case. Surg Today. 2001;31:895–8.

    Article  CAS  PubMed  Google Scholar 

  118. Iwata T, Inoue K, Morita R, Mizuguchi S, Tsukioka T, Onoda N, et al. Functional large parathyroid carcinoma extending into the superior mediastinum. Ann Thorac Cardiovasc Surg. 2008;14:112–5.

    PubMed  Google Scholar 

  119. Jarman WT, Myers RT, Marshall RB. Carcinoma of the parathyroid. Arch Surg. 1978;113:123–5.

    CAS  PubMed  Google Scholar 

  120. Kameyama K, Takami H. Double parathyroid carcinoma. Endocr J. 2003;50:477–9.

    Article  PubMed  Google Scholar 

  121. Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ. One stage treatment of parathyroid cancer. Eur J Surg Oncol. 2005;31:78–83.

    Article  CAS  PubMed  Google Scholar 

  122. Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, et al. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005;12:260–6.

    Article  PubMed  Google Scholar 

  123. Koyano H, Shishiba Y, Shimizu T, Suzuki N, Nakazawa H, Tachibana S, et al. Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma. Intern Med. 1994;33:697–702.

    Article  CAS  PubMed  Google Scholar 

  124. Larmi TK, Kairaluoma MI, Huttunen R, Mokka R, Rasanen. Parathyroid carcinoma. A case report. Acta Chir Scand. 1976;142:471–4.

    CAS  PubMed  Google Scholar 

  125. Lillemoe KD, Dudley NE. Parathyroid carcinoma: pointers to successful management. Ann R Coll Surg Engl. 1985;67:222–4.

    CAS  PubMed  Google Scholar 

  126. Mann K. Oral biphosphonate therapy in metastatic parathyroid carcinoma. Lancet. 1985;1:101–2.

    Article  CAS  PubMed  Google Scholar 

  127. Mashburn MA, Chonkich GD, Chase DR, Petti GH, Jr. Parathyroid carcinoma: two new cases–diagnosis, therapy, and treatment. Laryngoscope. 1987;97:215–8.

    Article  CAS  PubMed  Google Scholar 

  128. Masson EA, MacFarlane IA, Bodmer CW, Vaughan ED. Parathyroid carcinoma presenting with a brown tumour of the mandible in a young man. Br J Oral Maxillofac Surg. 1993;31:117–9.

    Article  CAS  PubMed  Google Scholar 

  129. McGarity WC, Boehm G. Carcinoma of the parathyroid. South Med J. 1975;68:166–8.

    CAS  PubMed  Google Scholar 

  130. McKeown PP, McGarity WC, Sewell CW. Carcinoma of the parathyroid gland: is it overdiagnosed? A report of three cases. Am J Surg. 1984;147:292–8.

    Article  CAS  PubMed  Google Scholar 

  131. Mezhir JJ, Melis M, Headley RC, Pai RK, Posner MC, Kaplan EL. Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection. J Hepatobiliary Pancreat Surg. 2007;14:410–3.

    Article  PubMed  Google Scholar 

  132. Montenegro FL. [On carcinoma of the parathyroid gland]. Arq Bras Endocrinol Metabol. 2006;50:571; author reply 572.

    PubMed  Google Scholar 

  133. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, et al.: Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378–84.

    Article  PubMed  Google Scholar 

  134. Neumann DR, Esselstyn CB, Kim EY. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings. J Nucl Med. 1996;37:2000–1.

    CAS  PubMed  Google Scholar 

  135. Nijs AM, Lether B, Misere JF, Lockefeer JH. A case of hyperparathyroidism caused by a parathyroid carcinoma. Case report and review of literature. Neth J Med. 1977;20:71–7.

    CAS  PubMed  Google Scholar 

  136. Obara T, Okamoto T, Ito Y, Yamashita T, Kawano M, Nishi T, et al. Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma. Surgery. 1993;114:1040–8; discussion 1048–9.

    CAS  PubMed  Google Scholar 

  137. Ou HY, Hung CJ, Hsu WH, Yu EH, Wu TJ. Variability of clinical presentations in three cases of parathyroid carcinoma. J Formos Med Assoc. 2003;102:266–9.

    PubMed  Google Scholar 

  138. Pahlavan PS, Severin MC. Parathyroid carcinoma: A rare case with mandibular brown tumor. Wien Klin Wochenschr. 2006;118:175–9.

    Article  PubMed  Google Scholar 

  139. Pai SI, Goldstein BJ, Studeman KD, Westra WH, Tufano RP. Concurrent sporadic parathyroid adenoma and carcinoma. Am J Otolaryngol. 2006;27:346–8.

    Article  PubMed  Google Scholar 

  140. Placzkowski K, Christian R, Chen H. Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med. 2007;32:358–60.

    Article  PubMed  Google Scholar 

  141. Pollack S, Goldin RR, Cohen M. Parathyroid carcinoma. A report of two cases and a review of the literature. Arch Intern Med. 1961;108:583–7.

    CAS  PubMed  Google Scholar 

  142. Qvist N, Kroll L, Ladefoged C, Blichert-Toft M, Rohr N. Parathyroid carcinoma: a case with recurrence treated with extensive vascular surgery to the neck. Eur J Surg Oncol. 1986;12:187–91.

    CAS  PubMed  Google Scholar 

  143. Rasmuson T, Kristoffersson A, Boquist L. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol. 2000;143:749–54.

    Article  CAS  PubMed  Google Scholar 

  144. Robert JH, Trombetti A, Garcia A, Pache JC, Herrmann F, Spiliopoulos A, et al. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Ann Surg Oncol. 2005;12:526–32.

    Article  PubMed  Google Scholar 

  145. Sahasranam P, Tran MT, Mohamed H, Friedman TC. Multiglandular parathyroid carcinoma: a case report and brief review. South Med J. 2007;100:841–4.

    PubMed  Google Scholar 

  146. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724–31.

    Article  CAS  PubMed  Google Scholar 

  147. Saunders KB, Richardson J. Carcinoma of the parathyroid. Proc R Soc Med. 1970;63:453–4.

    CAS  PubMed  Google Scholar 

  148. Schoretsanitis G, Melissas J, Kafousi M, Karkavitsas N, Tsiftsis DD. Synchronous parathyroid and papillary thyroid carcinoma: a case report. Am J Otolaryngol. 2002;23:382–5.

    Article  PubMed  Google Scholar 

  149. Severin MC, Jonas T. Parathyroid carcinoma. Isr Med Assoc J. 2003;5:604.

    PubMed  Google Scholar 

  150. Shapiro DM, Recant W, Hemmati M, Mazzone T, Evans RH. Synchronous occurrence of parathyroid carcinoma and adenoma in an elderly woman. Surgery. 1989;106:929–33.

    CAS  PubMed  Google Scholar 

  151. Sheehan JJ, Hill AD, Walsh MF, Crotty TB, McDermott EW, O’Higgins NJ. Parathyroid carcinoma: diagnosis and management. Eur J Surg Oncol. 2001;27:321–4.

    Article  CAS  PubMed  Google Scholar 

  152. Sinha S, Sinha A, McPherson GA. Synchronous sporadic carcinoma and primary hyperplasia of the parathyroid glands: A case report and review of the literature. Int J Surg Pathol. 2006;14:336–9.

    Article  CAS  PubMed  Google Scholar 

  153. Solorzano CC, Carneiro-Pla DM, Lew JI, Rodgers SE, Montano R, Irvin GL 3rd. Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer. Ann Surg Oncol. 2007;14:3216–22.

    Article  CAS  PubMed  Google Scholar 

  154. Sulak LE, Brown RW, Butler DB. Parathyroid carcinoma with occult bone metastases diagnosed by fine needle aspiration cytology. Acta Cytol. 1989;33:645–8.

    CAS  PubMed  Google Scholar 

  155. Tamura G, Miyoshi H, Ogata SY, Sasou S, Kudoh S, Kikuchi J, et al. Parathyroid carcinoma with anaplastic feature: association of a p53 gene mutation with anaplastic transformation. Pathol Int. 2009;59:107–10.

    Article  CAS  PubMed  Google Scholar 

  156. Tan GC, Shiran MS, Swaminathan M, Phang KS, Rohaizak M. Large retrosternal parathyroid carcinoma with primary hyperparathyroidism. Asian J Surg. 2007;30:286–9.

    Article  PubMed  Google Scholar 

  157. Thomas RJ, Bowling T, Cassoni AM, Sagar SM. Metastatic parathyroid carcinoma: a radiological, biochemical and symptomatic response to metastectomy. J R Soc Med. 1992;85:182.

    CAS  PubMed  Google Scholar 

  158. Tyler D, 3rd, Mandybur G, Dhillon G, Fratkin J. Intracranial metastatic parathyroid carcinoma: case report. Neurosurgery. 2001;48:937–9; discussion 939–40.

    Article  PubMed  Google Scholar 

  159. Vetto JT, Brennan MF, Woodruf J, Burt M. Parathyroid carcinoma: diagnosis and clinical history. Surgery. 1993;114:882–92.

    CAS  PubMed  Google Scholar 

  160. Vikram HR, Petito A, Bower BF, Goldberg MH. Parathyroid carcinoma diagnosed on the basis of a giant cell lesion of the maxilla. J Oral Maxillofac Surg. 2000;58:567–9.

    Article  CAS  PubMed  Google Scholar 

  161. Wiseman SM, Rigual NR, Hicks WL, Jr., Popat SR, Lore JM Jr, Douglas WG, et al. Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J. 2004;83:491–4.

    PubMed  Google Scholar 

  162. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197–205.

    CAS  Google Scholar 

  163. Yoshida S. Intracranial metastatic parathyroid carcinoma: case report. Surg Neurol. 2006;65:81–3.

    Article  PubMed  Google Scholar 

  164. Zisman E, Buckle RM, Deftos LJ, Aurbach GD, Morton DL, Bartter FC, et al. Production of parathyroid hormone by metastatic parathyroid carcinoma. Am J Med. 1968;45:619–23.

    Article  CAS  PubMed  Google Scholar 

  165. Barnes BA, Cope O. Carcinoma of the parathyroid glands, Report of 10 cases with endocrine function. JAMA. 1961;178:556–9.

    CAS  PubMed  Google Scholar 

  166. Davies DR, Dent CE, Ives DR. Successful removal of single metastasis in recurrent parathyroid carcinoma. Br Med J. 1973;1:397–8.

    Article  CAS  PubMed  Google Scholar 

  167. Ehrlich A, Mc DJ, Zitani A, Jr. Carcinoma of the parathyroid with hyperparathyroidism and metastases. JAMA. 1961;176:453–5.

    CAS  PubMed  Google Scholar 

  168. Gedik GK, Aksoy T, Bozkurt F, Ugur O, Caner B. Gamma probe-guided parathyroid cancer resection. Endocrinologist. 2008;18:71–2.

    Article  Google Scholar 

  169. Iacobone M, Ruffolo C, Lumachi F, Favia G. Results of iterative surgery for persistent and recurrent parathyroid carcinoma. In: First Meeting of the European-Society-of-Endocrine-Surgery (ESES), Pisa, Italy, 2004:385–90.

  170. Kern M, Lee G, Robbins P, Bynevelt M, Watson P. Intracranial metastatic parathyroid carcinoma—Case report and review of the literature. J Neurosurg. 2004;101:1065–9.

    Article  PubMed  Google Scholar 

  171. Lazar AW, Landau RL, Kappas A. Metastatic carcinoma of parathyroid and persistent hyperparathyroidism. Arch Pathol. 1961;72:484–9.

    CAS  PubMed  Google Scholar 

  172. Rufener JB, Cohen JI. Metachronous spread of parathyroid carcinoma to a retropharyngeal lymph node. Head Neck. 2003;25:968–71.

    Article  PubMed  Google Scholar 

  173. Rios L, Sapunar J, Roa I. Primary hyperparathyroidism with severe skeletal involvement in one patient with parathyroid carcinoma. Rev Med de Chile. 2005;133:77–81.

    Google Scholar 

  174. Grayzel EF. Hyperparathyroidism in a patient with parathyroid carcinoma—15-year follow-up. Arch Intern Med. 1967;120:349–52.

    Google Scholar 

  175. Robbins KT. Classification of neck dissection: current concepts and future considerations. Otolaryngol Clin North Am. 1998;31:639–55.

    Article  CAS  PubMed  Google Scholar 

  176. Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378–80.

    Article  CAS  PubMed  Google Scholar 

  177. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–44.

    Article  CAS  PubMed  Google Scholar 

  178. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109:1736–41.

    Article  PubMed  Google Scholar 

  179. Agarwal G, Prasad KK, Kar DK, Krishnani N, Pandey R, Mishra SK. Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology. World J Surg. 2006;30:732–42.

    Article  PubMed  Google Scholar 

  180. Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94:566–70.

    Article  CAS  PubMed  Google Scholar 

  181. Wang CA, Gaz RD. Natural history of parathyroid carcinoma. Diagnosis, treatment, and results. Am J Surg. 1985;149:522–7.

    Article  CAS  PubMed  Google Scholar 

  182. Mucci-Hennekinne S, Desolneux G, Luyckx F, Gibelin H, Mirallie E, De Calan L, et al. [Parathyroid carcinoma: multicenter study of 17 patients]. J Chir (Paris). 2008;145:133–7.

    CAS  Google Scholar 

  183. Fernandez-Ranvier GG, Khanafshar E, Jensen K, Zarnegar R, Lee J, Kebebew E, et al. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer. 2007;110:255–64.

    Article  PubMed  Google Scholar 

  184. Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136:878–85.

    Article  CAS  PubMed  Google Scholar 

  185. Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart P Jr, et al. Parathyroid carcinoma. Am J Surg. 1998;175:52–5.

    Article  CAS  PubMed  Google Scholar 

  186. Priya G, Jyotsna VP, Gupta N, Chumber S, Bal CS, Karak AK, et al. Clinical and laboratory profile of primary hyperparathyroidism in India. Postgrad Med J. 2008;84:34–9.

    Article  CAS  PubMed  Google Scholar 

  187. Falvo L, Catania A, D’Andrea V, Marzullo A, Giustiniani MC, De Antoni E. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg. 2005;241:640–6.

    Article  PubMed  Google Scholar 

  188. Gulcelik MA, Gulcelik NE, Kuru B, Camlibel M, Alagol H. Prognostic factors determining survival in differentiated thyroid cancer. J Surg Oncol. 2007;96:598–604.

    Article  PubMed  Google Scholar 

  189. Lo CY, Chan WF, Lam KY, Wan KY. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg. 2005;242:708–15.

    Article  PubMed  Google Scholar 

  190. D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004;100:1123–9.

    Article  PubMed  Google Scholar 

  191. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1991;66:11–22.

    CAS  PubMed  Google Scholar 

  192. Salmenkivi K, Heikkila P, Haglund C, Arola J. Malignancy in pheochromocytomas. APMIS. 2004;112:551–9.

    Article  PubMed  Google Scholar 

  193. Rodgers SE, Perrier ND. Parathyroid carcinoma. Curr Opin Oncol. 2006;18:16–22.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrine Surgery, King’s College Hospital, London, UK

    Nadia Talat BSc (hons.) & Klaus-Martin Schulte MD, FRCS

  2. Surgery, King’s College London, London, UK

    Klaus-Martin Schulte MD, FRCS

  3. King’s Health Partners, London, UK

    Nadia Talat BSc (hons.) & Klaus-Martin Schulte MD, FRCS

Authors
  1. Nadia Talat BSc (hons.)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaus-Martin Schulte MD, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus-Martin Schulte MD, FRCS.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Talat, N., Schulte, KM. Clinical Presentation, Staging and Long-Term Evolution of Parathyroid Cancer. Ann Surg Oncol 17, 2156–2174 (2010). https://doi.org/10.1245/s10434-010-1003-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1003-6

Keywords

Search

Navigation